does tirzepatide affect your liver Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A A summary of the beneficial

A gradual, individualised approach allows the body to adjust and helps maintain energy and social balance

Are you managing obesity as a chronic disease

Placer.ai analysis suggests that raising the cost of commitment filtered out casual shoppers and deepened engagement among members who do the math and visit more frequently to justify the fee

The ADA Standards of Care in Diabetes 2025 recommends the inclusion of medications with proven cardiovascular benefits in treatment plans for older patients with diabetes who have prior cardiovascular disease or multiple cardiovascular risks regardless of blood glucose levels [5]

JAMANetwork.com Frontiers in Endocrinology